Table of Contents Global Alpha Thalassemia Treatment Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Alpha Thalassemia Treatment Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Alpha Thalassemia Treatment Segment by Type 1.2.1 Folic Acid 1.2.2 Deferasirox 1.2.3 Deferiprone 1.2.4 Hydroxyurea 1.3 Market Analysis by Application 1.3.1 Hospitals 1.3.2 Ambulatory Surgical Centers 1.3.3 Others 1.4 Overview of Global Alpha Thalassemia Treatment Market 1.4.1 Global Alpha Thalassemia Treatment Revenue (2015-2025) 1.4.2 Global Alpha Thalassemia Treatment Production and Capacity (2015-2025) 1.4.3 North America Alpha Thalassemia Treatment Status and Prospect (2015-2025) 1.4.4 Europe Alpha Thalassemia Treatment Status and Prospect (2015-2025) 1.4.5 Japan Alpha Thalassemia Treatment Status and Prospect (2014-2025) 1.4.6 China Alpha Thalassemia Treatment Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Alpha Thalassemia Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Alpha Thalassemia Treatment Industry 1.6.2 Alpha Thalassemia Treatment Business Impact Assessment - Covid-19 1.6.3 Market Trends and Alpha Thalassemia Treatment Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Alpha Thalassemia Treatment Market Competition by Manufacturer 2.1 Global Alpha Thalassemia Treatment Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Alpha Thalassemia Treatment Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Alpha Thalassemia Treatment Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Alpha Thalassemia Treatment Manufacturer Market Share 2.5 Top 10 Alpha Thalassemia Treatment Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Alpha Thalassemia Treatment Market 2.7 Key Manufacturers Alpha Thalassemia Treatment Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Alpha Thalassemia Treatment Industry Key Manufacturers 3.1 GlaxoSmithKline 3.1.1 Company Details 3.1.2 Product Information 3.1.3 GlaxoSmithKline Alpha Thalassemia Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 GlaxoSmithKline News 3.2 Novartis AG 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Novartis AG Alpha Thalassemia Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Novartis AG News 3.3 Bellicum Pharmaceuticals 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Bellicum Pharmaceuticals Alpha Thalassemia Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Bellicum Pharmaceuticals News 3.4 Acceleron Pharma 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Acceleron Pharma Alpha Thalassemia Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Acceleron Pharma News 3.5 Johnson & Johnson 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Johnson & Johnson Alpha Thalassemia Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Johnson & Johnson News 3.6 Merck & Co. 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Merck & Co. Alpha Thalassemia Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Merck & Co. News 3.7 Gilead Sciences, Inc. 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Gilead Sciences, Inc. Alpha Thalassemia Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Gilead Sciences, Inc. News 4 Global Alpha Thalassemia Treatment Market Size Categorized by Regions (2015-2020) 4.1 Global Alpha Thalassemia Treatment Sales Market Share by Region 4.2 Global Alpha Thalassemia Treatment Revenue Market Share by Region (2015-2019) 4.3 Global Alpha Thalassemia Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Alpha Thalassemia Treatment Market Size Detail 4.4.1 North America Alpha Thalassemia Treatment Sales Growth Rate (2015-2020) 4.4.2 North America Alpha Thalassemia Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Alpha Thalassemia Treatment Market Size Detail 4.5.1 Europe Alpha Thalassemia Treatment Sales Growth Rate (2015-2020) 4.5.2 Europe Alpha Thalassemia Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Alpha Thalassemia Treatment Market Size Detail 4.6.1 Japan Alpha Thalassemia Treatment Sales Growth Rate (2015-2020) 4.6.2 Japan Alpha Thalassemia Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Alpha Thalassemia Treatment Market Size Detail 4.7.1 China Alpha Thalassemia Treatment Sales Growth Rate (2015-2020) 4.7.2 China Alpha Thalassemia Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Alpha Thalassemia Treatment Market Segment by Type 5.1 Global Alpha Thalassemia Treatment Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Alpha Thalassemia Treatment Sales and Market Share by Type (2015-2020) 5.1.2 Global Alpha Thalassemia Treatment Revenue and Market Share by Type (2015-2020) 5.2 Folic Acid Sales Growth Rate and Price 5.2.1 Global Folic Acid Sales Growth Rate (2015-2020) 5.2.2 Global Folic Acid Price (2015-2020) 5.3 Deferasirox Sales Growth Rate and Price 5.3.1 Global Deferasirox Sales Growth Rate (2015-2020) 5.3.2 Global Deferasirox Price (2015-2020) 5.4 Deferiprone Sales Growth Rate and Price 5.4.1 Global Deferiprone Sales Growth Rate (2015-2020) 5.4.2 Global Deferiprone Price (2015-2020) 5.5 Hydroxyurea Sales Growth Rate and Price 5.5.1 Global Hydroxyurea Sales Growth Rate (2015-2020) 5.5.2 Global Hydroxyurea Price (2015-2020) 6 Global Alpha Thalassemia Treatment Market Segment by Application 6.1 Global Alpha Thalassemia Treatment Sales Market Share by Application (2015-2020) 6.2 Hospitals Sales Growth Rate (2015-2020) 6.3 Ambulatory Surgical Centers Sales Growth Rate (2015-2020) 6.4 Others Sales Growth Rate (2015-2020) 7 Alpha Thalassemia Treatment Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Alpha Thalassemia Treatment Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Alpha Thalassemia Treatment Market Forecast 8.1 Global Alpha Thalassemia Treatment Sales, Revenue Forecast 8.1.1 Global Alpha Thalassemia Treatment Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Alpha Thalassemia Treatment Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Alpha Thalassemia Treatment Price and Trend Forecast (2020-2025) 8.2 Global Alpha Thalassemia Treatment Sales Forecast by Region (2020-2025) 8.2.1 North America Alpha Thalassemia Treatment Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Alpha Thalassemia Treatment Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Alpha Thalassemia Treatment Production, Revenue Forecast (2020-2025) 8.2.4 China Alpha Thalassemia Treatment Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Alpha Thalassemia Treatment Picture Table Global Alpha Thalassemia Treatment Sales by Type Figure Global Sales Market Share of Alpha Thalassemia Treatment by Product Type in 2019 Table Breakdown of Alpha Thalassemia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) Figure Alpha Thalassemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Folic Acid Picture Figure Deferasirox Picture Figure Deferiprone Picture Figure Hydroxyurea Picture Table Global Alpha Thalassemia Treatment Sales by Application Figure Global Alpha Thalassemia Treatment Sales Market Share by Application in 2019 Figure Hospitals Picture Figure Ambulatory Surgical Centers Picture Figure Others Picture Table Alpha Thalassemia Treatment Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Alpha Thalassemia Treatment Revenue (Million US$) (2015-2025) Figure Global Alpha Thalassemia Treatment Production (K Units) (2015-2025) Figure North America Alpha Thalassemia Treatment Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Alpha Thalassemia Treatment Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Alpha Thalassemia Treatment Revenue (Million US$) Growth Rate (2014-2025) Figure China Alpha Thalassemia Treatment Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Alpha Thalassemia Treatment Sales by Manufacturer (2018-2020) Figure Global Alpha Thalassemia Treatment Sales Market Share by Manufacturer in 2019 Table Global Alpha Thalassemia Treatment Revenue by Manufacturer (2018-2020) Figure Global Alpha Thalassemia Treatment Revenue Market Share by Manufacturer in 2019 Table Global Alpha Thalassemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Alpha Thalassemia Treatment Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Alpha Thalassemia Treatment Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Alpha Thalassemia Treatment Market Table Key Manufacturers Alpha Thalassemia Treatment Product Type Table Mergers & Acquisitions Planning Table GlaxoSmithKline Company Profile Figure Alpha Thalassemia Treatment Product Picture and Specifications of GlaxoSmithKline Table Alpha Thalassemia Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure GlaxoSmithKline Alpha Thalassemia Treatment Market Share (2018-2020) Table GlaxoSmithKline Main Business Table GlaxoSmithKline Recent Development Table Novartis AG Company Profile Figure Alpha Thalassemia Treatment Product Picture and Specifications of Novartis AG Table Alpha Thalassemia Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis AG Alpha Thalassemia Treatment Market Share (2018-2020) Table Novartis AG Main Business Table Novartis AG Recent Development Table Bellicum Pharmaceuticals Company Profile Figure Alpha Thalassemia Treatment Product Picture and Specifications of Bellicum Pharmaceuticals Table Alpha Thalassemia Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bellicum Pharmaceuticals Alpha Thalassemia Treatment Market Share (2018-2020) Table Bellicum Pharmaceuticals Main Business Table Bellicum Pharmaceuticals Recent Development Table Acceleron Pharma Company Profile Figure Alpha Thalassemia Treatment Product Picture and Specifications of Acceleron Pharma Table Alpha Thalassemia Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Acceleron Pharma Alpha Thalassemia Treatment Market Share (2018-2020) Table Acceleron Pharma Main Business Table Acceleron Pharma Recent Development Table Johnson & Johnson Company Profile Figure Alpha Thalassemia Treatment Product Picture and Specifications of Johnson & Johnson Table Alpha Thalassemia Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Johnson & Johnson Alpha Thalassemia Treatment Market Share (2018-2020) Table Johnson & Johnson Main Business Table Johnson & Johnson Recent Development Table Merck & Co. Company Profile Figure Alpha Thalassemia Treatment Product Picture and Specifications of Merck & Co. Table Alpha Thalassemia Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Merck & Co. Alpha Thalassemia Treatment Market Share (2018-2020) Table Merck & Co. Main Business Table Merck & Co. Recent Development Table Gilead Sciences, Inc. Company Profile Figure Alpha Thalassemia Treatment Product Picture and Specifications of Gilead Sciences, Inc. Table Alpha Thalassemia Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Gilead Sciences, Inc. Alpha Thalassemia Treatment Market Share (2018-2020) Table Gilead Sciences, Inc. Main Business Table Gilead Sciences, Inc. Recent Development Table Global Alpha Thalassemia Treatment Sales (K Units) by Region (2015-2020) Table Global Alpha Thalassemia Treatment Sales Market Share by Region (2015-2019) Figure Global Alpha Thalassemia Treatment Sales Market Share by Region (2015-2019) Figure Global Alpha Thalassemia Treatment Sales Market Share by Region in 2018 Table Global Alpha Thalassemia Treatment Revenue (Million US$) by Region (2015-2020) Table Global Alpha Thalassemia Treatment Revenue Market Share by Region (2015-2020) Figure Global Alpha Thalassemia Treatment Revenue Market Share by Region (2015-2020) Figure Global Alpha Thalassemia Treatment Revenue Market Share by Region in 2019 Table Global Alpha Thalassemia Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Alpha Thalassemia Treatment Sales (K Units) Growth Rate (2015-2020) Figure Europe Alpha Thalassemia Treatment Sales (K Units) Growth Rate (2015-2020) Table Europe Alpha Thalassemia Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Alpha Thalassemia Treatment Sales (K Units) Growth Rate (2015-2020) Table Japan Alpha Thalassemia Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Alpha Thalassemia Treatment Sales (K Units) Growth Rate (2015-2020) Table China Alpha Thalassemia Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Alpha Thalassemia Treatment Sales by Type (2015-2020) Table Global Alpha Thalassemia Treatment Sales Market Share by Type (2015-2020) Figure Global Alpha Thalassemia Treatment Sales Market Share by Type in 2019 Table Global Alpha Thalassemia Treatment Revenue by Type (2015-2020) Table Global Alpha Thalassemia Treatment Revenue Market Share by Type (2015-2020) Figure Global Alpha Thalassemia Treatment Revenue Market Share by Type in 2019 Figure Global Folic Acid Sales Growth Rate (2015-2025) Figure Global Folic Acid Price (2015-2020) Figure Global Deferasirox Sales Growth Rate (2015-2025) Figure Global Deferasirox Price (2015-2020) Figure Global Deferiprone Sales Growth Rate (2015-2025) Figure Global Deferiprone Price (2015-2020) Figure Global Hydroxyurea Sales Growth Rate (2015-2025) Figure Global Hydroxyurea Price (2015-2020) Table Global Alpha Thalassemia Treatment Sales Market Share by Application (2015-2020) Figure Global Alpha Thalassemia Treatment Sales Market Share by Application in 2019 Figure Global Hospitals Sales Growth Rate (2015-2025) Figure Global Ambulatory Surgical Centers Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Alpha Thalassemia Treatment Table Key Players of Downstream Markets Figure Sales Channel Figure Global Alpha Thalassemia Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Alpha Thalassemia Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Alpha Thalassemia Treatment Price and Trend Forecast (2020-2025) Table Global Alpha Thalassemia Treatment Sales (K Units) Forecast by Region (2020-2025) Figure Global Alpha Thalassemia Treatment Production Market Share Forecast by Region (2020-2025) Figure North America Alpha Thalassemia Treatment Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Alpha Thalassemia Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Alpha Thalassemia Treatment Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Alpha Thalassemia Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Alpha Thalassemia Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Alpha Thalassemia Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Alpha Thalassemia Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure China Alpha Thalassemia Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

GlaxoSmithKline Novartis AG Bellicum Pharmaceuticals Acceleron Pharma Johnson & Johnson